Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xintao Qiu

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Cell Reports|November 21, 2019
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate CancerJustin H Hwang, Ji-Heui Seo, Michael L Beshiri, et al.
Cancer Research|November 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E Stevens, Guillermo Peluffo, Xintao Qiu, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Nature Cancer|May 17, 2021
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C Watt, Paloma Cejas, Molly J DeCristo, et al.
Genome Medicine|June 27, 2026
ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistanceCristina Guarducci, Daniel Abravanel, Douglas Russo, et al.
Cancer Cell|May 8, 2026
Whole-genome doubling drives immune evasion by silencing antigen presentationPierre Foidart, Zheqi Li, Xinran Cai, et al.
Molecular Cancer Therapeutics|February 27, 2024
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate CancerAntje Neeb, Ines Figueiredo, Denisa Bogdan, et al.
Molecular Cell|May 17, 2020
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Hua-Jun Wu, Jennifer Y Ge, et al.
Nature Communications|October 2, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancerPaloma Cejas, Yingtian Xie, Alba Font-Tello, et al.
Cell Reports|December 15, 2023
Heterogeneity and transcriptional drivers of triple-negative breast cancerBojana Jovanović, Daniel Temko, Laura E Stevens, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Cell Reports|November 21, 2019
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate CancerJustin H Hwang, Ji-Heui Seo, Michael L Beshiri, et al.
Cancer Research|November 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E Stevens, Guillermo Peluffo, Xintao Qiu, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Nature Cancer|May 17, 2021
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C Watt, Paloma Cejas, Molly J DeCristo, et al.
Genome Medicine|June 27, 2026
ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistanceCristina Guarducci, Daniel Abravanel, Douglas Russo, et al.
Cancer Cell|May 8, 2026
Whole-genome doubling drives immune evasion by silencing antigen presentationPierre Foidart, Zheqi Li, Xinran Cai, et al.
Molecular Cancer Therapeutics|February 27, 2024
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate CancerAntje Neeb, Ines Figueiredo, Denisa Bogdan, et al.
Molecular Cell|May 17, 2020
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Hua-Jun Wu, Jennifer Y Ge, et al.
Nature Communications|October 2, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancerPaloma Cejas, Yingtian Xie, Alba Font-Tello, et al.
Cell Reports|December 15, 2023
Heterogeneity and transcriptional drivers of triple-negative breast cancerBojana Jovanović, Daniel Temko, Laura E Stevens, et al.
Pageof 7